The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 96.00, with a high estimate of 96.00 and a low estimate of 96.00. The median estimate represents a +42.20% increase from the last price of 67.51.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.49
Reporting Date Aug 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.